| The Effect of Periodic Therapy of Combined Tibolone, Synthetic Salmon Calcitonin
and Calcium in Osteoporotic Postmenopausal Women
|
| 폐경기 골다공증 여성에서의 티볼론, 합성 칼시토닌, 칼슘제재
주기적 병용 투여에 따른 치료 효과
|
| 박진영*,김태원,유문집 |
| 단국대학교 의과대학 정형외과학교실 |
|
|
| Abstract |
Background
Our study was designed to analyze the synergic effect after 2 times combined periodic therapy of tibolone, synthetic nasal spray type salmon calcitonin and calcium for 3 months each.
Methods
This study was based on 21 patients among 168 patients treated osteoporotic drug (combination therapy of tibolone, synthetic salmon calcitonin, calcium agent) from March 1995 to October 1999, with a minimum follow up 1 year. We compared preoperative bone mineral density (BMD) with postoperative BMD and laboratory finding (ionized calcium, phosphate, alkaline phosphatase in serum and calcium/creatinine ratio in urine) which were statistically analyzed.
Results
BMD was increased in spine (0.62 g/cm2 to 0.65 g/cm2) and not increased in hip (neck: 0.60 g/cm2 to 0.60 g/cm2, trochanter: 0.55 g/cm2 to 0.48 g/cm2, Ward's triangle: 0.37 g/cm2 to 0.38 g/cm2), but was not statistically significant (p>0.05). The laboratory finding was tendency of decreased bone metabolism (ionized calcium: 9.6 mg/dl to 9.3 mg/dl, phosphate: 4.2 mg/dl to 3.7 mg/dl, ALP: 99.9 IU/L to 83.0 IU/L in serum and calcium/creatinine ratio in urine: 10.9 to 9.1), but was not statistically significant (p>0.05).
Conclusion
In the osteoporotic post-menopausal women, the periodic combined therapy of tibolone, calcitonin and oral calcium agent did not show the syndergic effect in BMD and bone metabolism. This periodic combined therapy does not recommandable to osteoporotic post-menopausal women.
|
| Key Words:
Osteoporosis, Tibolone, Calcitonin, Bone mineral density, Bone metabolism |
|
PDF Links
Full text via DOI
Download Citation
